May temporarily increase Serotonin, GABA, Dopa, and other neurotransmitters in the body and brain for calmness, relaxation, and control. Neuro Links contains a complex of neurotransmitters found in the brain and body. Use Neuro Links in conjunction with amino acids to boost your neurotransmitters.
Adults: Take 15 drops under the tongue as needed up to six times a day or as directed by a health care professional. Children: Take 5 drops per 50 pounds of body weight or as directed by a health care professional.
www.painstresscenter.com5-METHOXYTRYPTAMINE 12X, ACETYLCHOLINE CHLORIDE 12X, DOPAMINE HYDROCHLORIDE 12X, GABA (GAMMA-AMINOBUTYRIC ACID) 12X, HISTAMINUM HYDROCHLORICUM 12X, L-DOPA 12X, MELATONIN 12X, NOREPINEPHRINE 12X, PHENETHYLAMINE (PEA) 12X, SEROTONIN (HYDROCHLORIDE) 12X, TAURINE 12X, TYRAMINE 12X
May temporarily increase Serotonin, GABA, Dopa, and other neurotransmitters in the body and brain for calmness, relaxation, and control.
Neuro Links contains a complex of neurotransmitters found in the brain and body. Use Neuro Links in conjunction with amino acids to boost your neurotransmitters.
Keep out of reach of children. In case of overdose, get medical help or contact Poison Control Center right away.
DO NOT expose to heat. Store tightly closed in a cool, dry place.
Safety Sealed for your protection and product freshness. Do not use if safety seal is broken or missing.
Warnings:
Do not use with SSRIs, SSNIs, MAOs, or TCA (tricyclic antidepressants). If pregnant or lactating, consult your health care professional.
Keep out of reach of children. In case of overdose, get medical help or contact Poison Control Center right away.
Adults: Take 15 drops under the tongue as needed up to six times a day or as directed by a health care professional.
Children: Take 5 drops per 50 pounds of body weight or as directed by a health care professional.
May temporarily increase Serotonin, GABA, Dopa, and other neurotransmitters in the body and brain for calmness, relaxation, and control.
Neuro Links contains a complex of neurotransmitters found in the brain and body. Use Neuro Links in conjunction with amino acids to boost your neurotransmitters.
CITRIC ACID, DEMINERALIZED WATER, GLYCERIN, SODIUM BENZOATE
PSC Products
NDC 60564-0002-1
Neuro Links
Homeopathic
1 Fl. Oz. (30 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60564-0002-1 | 2021-12-22 | C162847 | 48780-1 | 9d75b9d0-0e5f-f424-e053-dadaa90a57ce | DRUG FACTS: |
| 60564-0002-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0e5f-f424-e053-dadaa90a57ce | DRUG FACTS: |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .GAMMA.-AMINOBUTYRIC ACID | ACTIVE INGREDIENT | 2ACZ6IPC6I | 1 | |
| 5-METHOXYTRYPTAMINE | ACTIVE INGREDIENT | 3VMW6141KC | 1 | |
| ACETYLCHOLINE CHLORIDE | ACTIVE INGREDIENT | AF73293C2R | 1 | |
| DOPAMINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7L3E358N9L | 1 | |
| HISTAMINE DIHYDROCHLORIDE | ACTIVE INGREDIENT | 3POA0Q644U | 1 | |
| LEVODOPA | ACTIVE INGREDIENT | 46627O600J | 1 | |
| MELATONIN | ACTIVE INGREDIENT | JL5DK93RCL | 1 | |
| NOREPINEPHRINE | ACTIVE INGREDIENT | X4W3ENH1CV | 1 | |
| PHENETHYLAMINE | ACTIVE INGREDIENT | 327C7L2BXQ | 1 | |
| SEROTONIN HYDROCHLORIDE | ACTIVE INGREDIENT | GKN429M9VS | 1 | |
| TAURINE | ACTIVE INGREDIENT | 1EQV5MLY3D | 1 | |
| TYRAMINE | ACTIVE INGREDIENT | X8ZC7V0OX3 | 1 | |
| .GAMMA.-AMINOBUTYRIC ACID | ACTIVE MOIETY | 2ACZ6IPC6I | 1 | |
| 5-METHOXYTRYPTAMINE | ACTIVE MOIETY | 3VMW6141KC | 1 | |
| ACETYLCHOLINE | ACTIVE MOIETY | N9YNS0M02X | 1 | |
| DOPAMINE | ACTIVE MOIETY | VTD58H1Z2X | 1 | |
| HISTAMINE | ACTIVE MOIETY | 820484N8I3 | 1 | |
| LEVODOPA | ACTIVE MOIETY | 46627O600J | 1 | |
| MELATONIN | ACTIVE MOIETY | JL5DK93RCL | 1 | |
| NOREPINEPHRINE | ACTIVE MOIETY | X4W3ENH1CV | 1 | |
| PHENETHYLAMINE | ACTIVE MOIETY | 327C7L2BXQ | 1 | |
| SEROTONIN | ACTIVE MOIETY | 333DO1RDJY | 1 | |
| TAURINE | ACTIVE MOIETY | 1EQV5MLY3D | 1 | |
| TYRAMINE | ACTIVE MOIETY | X8ZC7V0OX3 | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60564-0002 | 60564-0002-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| 5-METHOXYTRYPTAMINE | 3VMW6141KC | ACTIM |
| ACETYLCHOLINE CHLORIDE | AF73293C2R | ACTIB |
| DOPAMINE HYDROCHLORIDE | 7L3E358N9L | ACTIB |
| .GAMMA.-AMINOBUTYRIC ACID | 2ACZ6IPC6I | ACTIB |
| HISTAMINE DIHYDROCHLORIDE | 3POA0Q644U | ACTIB |
| LEVODOPA | 46627O600J | ACTIB |
| MELATONIN | JL5DK93RCL | ACTIB |
| NOREPINEPHRINE | X4W3ENH1CV | ACTIB |
| PHENETHYLAMINE | 327C7L2BXQ | ACTIB |
| SEROTONIN HYDROCHLORIDE | GKN429M9VS | ACTIB |
| TAURINE | 1EQV5MLY3D | ACTIB |
| TYRAMINE | X8ZC7V0OX3 | ACTIB |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM / SUBLINGUAL | 10 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOAP / TOPICAL | 0.5 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | 160 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | FILM, SOLUBLE / BUCCAL | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / ORAL | 28 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / NASAL | 2.8 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | 20 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION, SOLUTION / INTRAMUSCULAR | 4.8 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DOUCHE / VAGINAL | 0.07 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / SUBCUTANEOUS | 26 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a66b835e-ca06-4144-b0fa-2c1c8c127cbc | 160afc8d-b485-41ac-97ad-96f567ace387 | 2021-12-22 | Warnings | a66b835e-ca06-4144-b0fa-2c1c8c127cbc 160afc8d-b485-41ac-97ad-96f567ace387 |
Adverse event summaries are temporarily unavailable. Other product information remains available.